AJP - Endo Information on EB 2010
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab 291: E611-E620, 2006. First published April 25, 2006; doi:10.1152/ajpendo.00034.2006
0193-1849/06 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
291/3/E611    most recent
00034.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Phan, L. K.
Right arrow Articles by Leibel, R. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Phan, L. K.
Right arrow Articles by Leibel, R. L.

The mahoganoid mutation (Mgrn1md) improves insulin sensitivity in mice with mutations in the melanocortin signaling pathway independently of effects on adiposity

Loan K. Phan,1,2 Wendy K. Chung,1,3 and Rudolph L. Leibel1,2,3

1Division of Molecular Genetics, Department of Pediatrics; 2Institute of Human Nutrition; and 3Naomi Berrie Diabetes Center, Columbia University, New York, NY

Submitted 7 April 2006 ; accepted in final form 23 April 2006

Mahoganoid (Mgrn1md) is a mutation of the mahogunin (Mgrn1) gene. The hypomorphic allele suppresses the yellow pigmentation and obesity of the Ay mouse that ubiquitously overexpresses agouti signaling protein (ASP). To assess the physiological effects of MGRN1 on energy and glucose homeostasis, we generated animals doubly mutant for Mgrn1md and Ay, Lepob, or a null allele of Mc4r, and diet-induced obesity (DIO) mice segregating for Mgrn1md. Mgrn1md suppressed the obesity, hyperglycemia, and hyperinsulinemia of Ay mice. Mgrn1md suppressed Ay-induced obesity by reducing food intake, and reduced adiposity in Lepob/Lepob females, but did not alter the body weight or body composition of mice fed a high-fat diet. There was no effect of Mgrn1md on weight gain, body composition, energy intake, or energy expenditure in Mc4r-null animals. Mgrn1md reduced circulating insulin concentrations in DIO, Ay, and Mc4r-null but not Lepob/Lepob mice. The effect of Mgrn1md on circulating insulin concentrations was not due primarily to reductions in fat mass, since the plasma insulin concentrations of Mgrn1md mice segregating for either Ay or Mc4r-null alleles, adjusted for fat mass and plasma glucose, were reduced compared with Ay and Mc4r mice, respectively. The effect of Mgrn1md on insulin sensitivity of Mc4r-null mice suggests that Mgrn1md may be increasing insulin sensitivity via the hypothalamic melanocortin-3 receptor pathway.

agouti; insulin resistance; melanocortin-4 receptor; obesity; mahogany



Address for reprint requests and other correspondence: R. L. Leibel, Russell Berrie Medical Science Pavilion, 1150 St. Nicholas Ave., Room 620, New York, NY 10032 (e-mail: rl232{at}columbia.edu)







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2006 by the American Physiological Society.